WITHDRAWN: Irinotecan plus Weekly 5-Fluorouracil and Leucovorin as Salvage Treatment for Patients with Metastatic Colorectal Cancer: A Phase II Trial

By  

Digestive Diseases, Vol. 25, Iss. 1, 2007-03 ,pp. : 100-105

Karger

Access to resources Recommend Favorite

Effects of Cyclooxygenase-2 Inhibition on Serum and Tumor Gastrins and Expression of Apoptosis-Related Proteins in Colorectal Cancer

By Konturek Peter   Rembiasz Kazimierz   Burnat Grzegorz   Konturek Stanisław   Tusinela Marcin   Bielanski Władysław   Rehfeld Jens   Karcz Danuta   Hahn Eckhart  

Digestive Diseases and Sciences, Vol. 51, Iss. 4, 2006-04 ,pp. : 779-787

Springer Publishing Company

Access to resources Recommend Favorite

Absence of Therapeutic Efficacy of the Somatostatin Analogue Lanreotide in Advanced Primary Hepatic Cholangiocellular Cancer and Adenocarcinoma of the Gallbladder Despite In Vivo SomatostatinReceptor Expression

By Fiebiger W. C. C.   Scheithauer W.   Traub T.   Kurtaran A.   Gedlicka C.   Kornek G. V.   Virgolini I.   Raderer M.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 2, 2002-02 ,pp. : 222-225

Informa Healthcare

Access to resources Recommend Favorite

Colorectal cancer prognosis and PPARδ/β expression in the tumor microenvironment

By Mazzoccoli Gianluigi  

Journal of Gastroenterology, Vol. 49, Iss. 3, 2014-03 ,pp. : 564-565

Springer Publishing Company

Access to resources Recommend Favorite

Biomarkers for Predicting the Efficacy of Anti-Epidermal Growth Factor Receptor Antibody in the Treatment of Colorectal Cancer

By  

Digestion, Vol. 89, Iss. 1, 2014-01 ,pp. : 18-23

Karger

Access to resources Recommend Favorite